<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26009802</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Is a multivalent hand, foot, and mouth disease vaccine feasible?</ArticleTitle><Pagination><StartPage>2688</StartPage><EndPage>2704</EndPage><MedlinePgn>2688-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2015.1049780</ELocationID><Abstract><AbstractText>Enterovirus A infections are the primary cause of hand, foot and mouth disease (HFMD) in infants and young children. Although enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16) are the predominant causes of HFMD epidemics worldwide, EV-A71 has emerged as a major neurovirulent virus responsible for severe neurological complications and fatal outcomes. HFMD is a serious health threat and economic burden across the Asia-Pacific region. Inactivated EV-A71 vaccines have elicited protection against EV-A71 but not against CV-A16 infections in large efficacy trials. The current development of a bivalent inactivated EV-A71/CV-A16 vaccine is the next step toward that of multivalent HFMD vaccines. These vaccines should ultimately include other prevalent pathogenic coxsackieviruses A (CV-A6 and CV-A10), coxsackieviruses B (B3 and B5) and echovirus 30 that often co-circulate during HFMD epidemics and can cause severe HFMD, aseptic meningitis and acute viral myocarditis. The prospect and challenges for the development of such multivalent vaccines are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a VaxioBio Inc. ; Toronto, Ontario , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Pele</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>b Vaccine R&amp;D Center; National Health Research Institutes ; Zhunan Town, Miaoli County , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Graduate Institute of Immunology; China Medical University ; Taichung , Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71 vaccine</Keyword><Keyword MajorTopicYN="N">bivalent and multivalent vaccines</Keyword><Keyword MajorTopicYN="N">coxsackievirus A16</Keyword><Keyword MajorTopicYN="N">coxsackieviruses B3 and B5</Keyword><Keyword MajorTopicYN="N">echovirus 30</Keyword><Keyword MajorTopicYN="N">enterovirus A (EV-A)</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">foot and mouth diseases</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">inactivated whole virion vaccines</Keyword><Keyword MajorTopicYN="N">monovalent</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26009802</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch M, Oberste MS, Whitton JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses In Fields Virology, 6th edn, Fields BN, Knipe DM, Howley PM (eds). Phildelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins Health, 490-530, 2013.</Citation></Reference><Reference><Citation>Tapparel C. Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 2013; 14:282-93; PMID:23201849; http://dx.doi.org/10.1016/j.meegid.2012.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001; 11:355-68; PMID:11746998; http://dx.doi.org/10.1002/rmv.326</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.326</ArticleId><ArticleId IdType="pubmed">11746998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B, Davies HD. Aseptic meningitis. Curr Opin Infect Dis 2007; 20:272-7; PMID:17471037; http://dx.doi.org/10.1097/QCO.0b013e3280ad4672</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e3280ad4672</ArticleId><ArticleId IdType="pubmed">17471037</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10:778-90; PMID:20961813; http://dx.doi.org/10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2012; 2:199-205; PMID:22482716; http://dx.doi.org/10.1016/j.coviro.2012.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CCY, Lau SKP, Woo PCY, Yuen KA. Human enterovirus 71 epidemics: what's next? Emerg Health Threats J 2013; 6:19780; PMID:24119538</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother 2014; 10:360-7; PMID:24231751; http://dx.doi.org/10.4161/hv.27087</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SL, Pan H, Liu P, Amer S, Chan TC, Zhan J, Huo X, Liu Y, Teng Z, Wang L, et&#xa0;al.. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol 2015; 25(2):115-28; PMID:25704797; http://dx.doi.org/10.1002/rmv.1827</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1827</ArticleId><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca MC, Sarmiento L, Resik S, Mart&#xed;nez Y, Hung LH, Morier L, Pi&#xf1;&#xf3;n A, Vald&#xe9;z O, Kour&#xed; V, Gonz&#xe1;lez G. Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013. Arch Virol 2014; 159:2451-5; PMID:24719197; http://dx.doi.org/10.1007/s00705-014-2071-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2071-x</ArticleId><ArticleId IdType="pubmed">24719197</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) . Notes from the field: severe hand, foot and mouth disease associated with coxsackievirus A6 - Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep 2012; 61:213-4; PMID:22456122</Citation><ArticleIdList><ArticleId IdType="pubmed">22456122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Zhang T, Hu Y, Wang X, Du J, Li Y, Sun S, Sun X, Li Z, Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 2011; 8:508-11; PMID:22054534; http://dx.doi.org/10.1186/1743-422X-8-508</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-508</ArticleId><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu QB, Zhang XA, Wo Y, Xu HM, Li XJ, Wang XJ, Ding SJ, Chen XD, He C, Liu LJ, et&#xa0;al.. Circulation of coxsackievirus A10 and A6 in hand, foot and mouth disease in China, 2009-2011. PLoS One 2012; 7(12):e52073; PMID:23272213; http://dx.doi.org/10.1371/journal.pone.0052073</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052073</ArticleId><ArticleId IdType="pmc">PMC3525556</ArticleId><ArticleId IdType="pubmed">23272213</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, Qin K, Liu Y, Wu J. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot and mouth disease in Central China. PLoS One 2014; 9(4):e96051; PMID:24776922; http://dx.doi.org/10.1371/journal.pone.0096051</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096051</ArticleId><ArticleId IdType="pmc">PMC4002479</ArticleId><ArticleId IdType="pubmed">24776922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongyan G, Chengile M, Qiaozhi Y, Wenhao H, Juan L, Lin P, Yanli X, Hongshan W, Xingwang L. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013. Pediatr Infect Dis J 2014; 33:1302-3; PMID:25037037; http://dx.doi.org/10.1097/INF.0000000000000467</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000467</ArticleId><ArticleId IdType="pubmed">25037037</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Jiang T, Fan XL, Yang LM, Yu M, Cao RY, Wang JZ, Qin ED, Qin CF. Recombination of human coxsackievirus B5 in hand, foot and mouth disease patients, China. Emerg Infect Dis 2012; 18:351-3; PMID:22305307; http://dx.doi.org/10.3201/eid1802.111524</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.111524</ArticleId><ArticleId IdType="pmc">PMC3310474</ArticleId><ArticleId IdType="pubmed">22305307</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Xu S, Zhang Y, Zhu SY, Wu DL, Yang XD, Liu H, Sun BX, Wu XY, Qin CF. Hand, foot and mouth disease outbreak caused by coxsackievirus A6, China 2013. J Infect 2014; 69:303-5; PMID:24704297; http://dx.doi.org/10.1016/j.jinf.2014.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2014.03.015</ArticleId><ArticleId IdType="pubmed">24704297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JF, Zhang RS, Ou XH, Chen FM, Sun BC. The role of enterovirus 71 and coxsackievirus A strains in a large outbreak of hand, foot and mouth disease in Changsha, China. Int J Infect Dis 2014; 28:17-25; PMID:25236389; http://dx.doi.org/10.1016/j.ijid.2014.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.07.024</ArticleId><ArticleId IdType="pubmed">25236389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et&#xa0;al.. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand, foot and mouth disease in Fuyang city of China. Virol J 2010; 7:94-102; PMID:20459851; http://dx.doi.org/10.1186/1743-422X-7-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>He SJ, Han JF, Ding XX, Wang YD, Qin CF. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot and mouth disease patients in Guandong, 2010. Int J Infect Dis 2013; 17:e1025-30; PMID:23791223; http://dx.doi.org/10.1016/j.ijid.2013.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2013.04.003</ArticleId><ArticleId IdType="pubmed">23791223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Zeng H, Zheng H, Yi L, Guo X, Liu L, Sun L, Tan X, Li H, Ke C, Lin J. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect 2014; 20:O442-5; PMID:24428125; http://dx.doi.org/10.1111/1469-0691.12468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12468</ArticleId><ArticleId IdType="pubmed">24428125</ArticleId></ArticleIdList></Reference><Reference><Citation>Di B, Zhang Y, Xie H, Li X, Chen C, Ding P, He P, Wang D, Geng J, Luo L, et&#xa0;al.. Circulation of coxsackievirus A6 in hand-foot-and-mouth disease in Guangzhou, 2010-2012. Virol J 2014; 11:157-63; PMID:25178398; http://dx.doi.org/10.1186/1743-422X-11-157</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-157</ArticleId><ArticleId IdType="pmc">PMC4169826</ArticleId><ArticleId IdType="pubmed">25178398</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Cao RY, Jiang T, Yu M, Liu W, Tian X, Qin ED, Cao WC, Qin CF. Echovirus 30 in EV71-associated hand, foot and mouth disease outbreak, Guanxi, China. J Clin Virol 2011; 50:348-9; PMID:21306942; http://dx.doi.org/10.1016/j.jcv.2011.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.01.005</ArticleId><ArticleId IdType="pubmed">21306942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Zhang Y, Sun Q, Zhu S, Li X, Pan Z, Xu W, Xu B. Prevalence of multiple enteroviruses associated with hand, foot and mouth disease in Shijiazhuang city, Hebei province, China: outbreaks of coxsackieviruses a10 and b3. PLoS One 2014; 9(1):e84233; PMID:24392117; http://dx.doi.org/10.1371/journal.pone.0084233</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084233</ArticleId><ArticleId IdType="pmc">PMC3879295</ArticleId><ArticleId IdType="pubmed">24392117</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Jiang J, Liu Y, Huang X, Wang P, Liu L, Wang J, Chen W, Wu W, Xu B. Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot and mouth disease in Henan Province, China in 2009. Virus Genes 2013; 46:1-9; PMID:23080402; http://dx.doi.org/10.1007/s11262-012-0814-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-012-0814-x</ArticleId><ArticleId IdType="pubmed">23080402</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan HY, Yang MJ, Liu LZ, Wang J, Yang GL, Zhang W, Ma XJ, Wang CR. Pathogenic spectrum of enteroviruses associated with hand, foot and mouth disease by a GeXPTM-based multiplex reverse transcription-PCR assay in Jinan, China, 2009-2012. Bing Du Xue Bao 2014; 30:567-71; PMID:25562968</Citation><ArticleIdList><ArticleId IdType="pubmed">25562968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang H, Ding S, Wang X, Chen X, Wo Y, Wang L, Huang D, Liu W, Cao W. Prevalence of enteroviruses in children with and without hand, foot and mouth disease in China. BMC Infect Dis 2013; 13:606-13; PMID:24370001; http://dx.doi.org/10.1186/1471-2334-13-606</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-606</ArticleId><ArticleId IdType="pmc">PMC3890605</ArticleId><ArticleId IdType="pubmed">24370001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H, Yi B, Yin J, Fang T, He T, Du Y, Wang J, Zhang H, Xie L, Ding Y, et&#xa0;al.. Epidemiological and etiological characteristics of hand, foot and mouth disease in Ningbo, China, 2008-2011. J Clin Virol 2012; 54:342-8; PMID:22652041; http://dx.doi.org/10.1016/j.jcv.2012.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2012.04.021</ArticleId><ArticleId IdType="pubmed">22652041</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Wang X, Hu Y, Li Z, Li Y, Sun S, Yang F, Jin Q. Changing aetiology of hand, foot and mouth disease in Linyi, China, 2009-2011. Clin Microbiol Infect 2014; 20:O47-9; PMID:23910234; http://dx.doi.org/10.1111/1469-0691.12301</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12301</ArticleId><ArticleId IdType="pubmed">23910234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Yang F, Du J, Zhang T, Xue Y, Jin Q. Coxsackie B5 associated with neurological hand, foot and mouth disease, China. J Infect 2012; 65:189-91; PMID:22484273; http://dx.doi.org/10.1016/j.jinf.2012.03.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2012.03.021</ArticleId><ArticleId IdType="pubmed">22484273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Du J, Xue Y, Su H, Yang F, Jin Q. Epidemics and frequent recombination within species in outbreaks of human enteroviruses B-associated hand, foot and mouth disease in Shangdong China in 2010 and 2011. PLoS One 2013; 8(6):e67157; PMID:23840610; http://dx.doi.org/10.1371/journal.pone.0067157</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067157</ArticleId><ArticleId IdType="pmc">PMC3686723</ArticleId><ArticleId IdType="pubmed">23840610</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Zhang Y, Hou PQ, Zhu SY, Wu XY, Zhao H, Yu M, Qin CF. Human enterovirus co-infection in severe HFMD patients in China. J Clin Virol 2014; 61:621-2; PMID:25449173; http://dx.doi.org/10.1016/j.jcv.2014.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.09.005</ArticleId><ArticleId IdType="pubmed">25449173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan XF, Gao S, Xia JF, Ye R, Yu H, Long JE. Epidemic characteristic of hand, foot and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis 2012; 44:297-305; PMID:22176514; http://dx.doi.org/10.3109/00365548.2011.634433</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.634433</ArticleId><ArticleId IdType="pubmed">22176514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, Li YF, Wang XH, Lu GP, Shen HG, Yu H, Zhu QR. Epidemiology of hand, foot and mouth disease in children in Shanghai 2007-2010. Epidemiol Infect 2012; 140:1122-30; PMID:21878145; http://dx.doi.org/10.1017/S0950268811001622</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268811001622</ArticleId><ArticleId IdType="pubmed">21878145</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Su L, Cao L, Zhong H, Dong N, Xu J. Enterovirus genotypes causing hand, foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis 2013; 13:489-97; PMID:24148902; http://dx.doi.org/10.1186/1471-2334-13-489</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-489</ArticleId><ArticleId IdType="pmc">PMC4015791</ArticleId><ArticleId IdType="pubmed">24148902</ArticleId></ArticleIdList></Reference><Reference><Citation>He YQ, Chen L, Xu WB, Yang H, Wang HZ, Zong WP, Xian HX, Chen HL, Yao XJ, Hu ZL, et&#xa0;al.. Emergence, circulation and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot and mouth disease infections from 2010 to 2012 in Shenzhen, China. J Clin Microbiol 2013; 51:3560-6; PMID:23966496; http://dx.doi.org/10.1128/JCM.01231-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01231-13</ArticleId><ArticleId IdType="pmc">PMC3889734</ArticleId><ArticleId IdType="pubmed">23966496</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JL, Yuan J, Yang F, Wu ZQ, Hu YF, Xue Y, Zhou BP, Jin Q. Epidemic characteristics of hand, foot and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent. J. Infect 2014; 69:299-303; PMID:24731881; http://dx.doi.org/10.1016/j.jinf.2014.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2014.04.001</ArticleId><ArticleId IdType="pubmed">24731881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X, Li L, Zhang B, Jorba J, Su X, Ji T, Yang D, Lv L, Li J, Xu W. Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot and mouth disease in Tianjin, China, in 2013. Arch Virol 2015; 160:1097-104; PMID:25680566; http://dx.doi.org/10.1007/s00705-015-2340-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2340-3</ArticleId><ArticleId IdType="pmc">PMC4629805</ArticleId><ArticleId IdType="pubmed">25680566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Mou X, Zhang Q, Li Y, Lin J, Liu F, Yuan L, Tang Y, Xiang C. Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China. Mol Med Rep 2012; 5:1001-4; PMID:22218731</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493055</ArticleId><ArticleId IdType="pubmed">22218731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalkrishna V, Patil PR, Patil GP, Chitambar SD. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol 2012; 61:420-5; PMID:22052995; http://dx.doi.org/10.1099/jmm.0.036400-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.036400-0</ArticleId><ArticleId IdType="pubmed">22052995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar BR, Dwibedi B, Kar SK. An outbreak of hand, foot and mouth in Bhubaneswar, Odisha. Indian Pediatr 2013; 50:139-42; PMID:22728634; http://dx.doi.org/10.1007/s13312-013-0033-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-013-0033-0</ArticleId><ArticleId IdType="pubmed">22728634</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 2012; 6(8):e1737; PMID:22953003; http://dx.doi.org/10.1371/journal.pntd.0001737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001737</ArticleId><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, et&#xa0;al.. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 2009; 62:254-9; PMID:19628900</Citation><ArticleIdList><ArticleId IdType="pubmed">19628900</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano T, Saito T, Kondo M, Watanabe S, Onoue Y, Konnai M, Sato Y, Orihara N. Enterovirus detection status of patients with herpangina and hand, foot and mouth disease in epidemic season 2007, Kanagawa Prefecture, Japan. Jpn J Infect Dis 2008; 61:162-3; PMID:18362414</Citation><ArticleIdList><ArticleId IdType="pubmed">18362414</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto A, Hirata R, Ishimoto K, Hisatomi M, Wasada R, Akita Y, Ishihara T, Fujimoto T, Eshima N, Hatano Y, et&#xa0;al.. An outbreak of hand-foot-and-mouth disease mimicking chicken pox, with a frequent association of onychomadesis in Japan in 2009: a new phenotype caused by coxsackievirus A6. Eur J Dermatol 2014; 24:103-4; PMID:24334231</Citation><ArticleIdList><ArticleId IdType="pubmed">24334231</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, Okabe N, Yoshida H, Yasui Y, Kobayashi M, et&#xa0;al.. Hand, foot and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis 2012; 18:337-9; PMID:22304983; http://dx.doi.org/10.3201/eid1802.111147</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1802.111147</ArticleId><ArticleId IdType="pmc">PMC3310456</ArticleId><ArticleId IdType="pubmed">22304983</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Lee BH, Baek KA, Cheon D, Yeo S, Park J, Soh J, Cheon H, Yoon K, Choi Y. Enteroviruses isolated from herpangina and hand, foot and mouth disease in Korean children. Virol J 2012; 9:205-10; PMID:22985487; http://dx.doi.org/10.1186/1743-422X-9-205</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-205</ArticleId><ArticleId IdType="pmc">PMC3490919</ArticleId><ArticleId IdType="pubmed">22985487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua KB, Kasri AR. Hand, foot and mouth disease due to enterovirus 71 in Malaysia. Virol Sin 2011; 26:221-8; PMID:21847753; http://dx.doi.org/10.1007/s12250-011-3195-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3195-8</ArticleId><ArticleId IdType="pmc">PMC8222466</ArticleId><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009; 38:106-12; PMID:19271036</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VT. The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus71 and coxsackievirus A strains. Int J Infect Dis 2010; 14:e1076-81; PMID:20952237; http://dx.doi.org/10.1016/j.ijid.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and hyperangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007; 120:e245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo SH, Huang YC, Huang CG, Tsao KC, Li WC, Hsieh YC, Chiu CH, Lin TY. Clinical and epidemiologic features of coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect 2011; 44:252-7; PMID:21524960; http://dx.doi.org/10.1016/j.jmii.2011.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.031</ArticleId><ArticleId IdType="pubmed">21524960</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CH, Lu CY, Shao PL, Lee PI, Kao CL, Chung MY, Chang LY, Huang LM. Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect 2011; 44:265-73; PMID:21524954; http://dx.doi.org/10.1016/j.jmii.2011.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.029</ArticleId><ArticleId IdType="pubmed">21524954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Huang LM, Wong WW, Wu TZ, Chiu TF, Chang LY. Molecular diagnosis and clinical presentations of enteroviral infections in Taipei during the 2008 epidemic. J Microbiol Immunol Infect 2011; 44:178-83; PMID:21524611; http://dx.doi.org/10.1016/j.jmii.2011.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.018</ArticleId><ArticleId IdType="pubmed">21524611</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Lu CY, Cheng AL, Chang LY. Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J 2013; 10:209-17; PMID:23800163; http://dx.doi.org/10.1186/1743-422X-10-209</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-209</ArticleId><ArticleId IdType="pmc">PMC3717056</ArticleId><ArticleId IdType="pubmed">23800163</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Chieochansin T, Linsuwanon P, Korkong S, Thongkomplew S, Vichaiwattana P, Theamboonlers A, Poovorawan Y. et&#xa0;al.. Hand, foot and mouth disease caused by coxsackievirus A6, Thailand, 2012. Emerg Infect Dis 2013; 19:641-3; PMID:23631943; http://dx.doi.org/10.3201/eid1904.121666</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1904.121666</ArticleId><ArticleId IdType="pmc">PMC3647428</ArticleId><ArticleId IdType="pubmed">23631943</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Mauleekoonphairoj J, Linsuwanon P, Suwannakarn K, Chieochansin T, Korkong S, Theamboonlers A, Poovorawan Y. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One 2014; 9(6):e98888; PMID:24887237; http://dx.doi.org/10.1371/journal.pone.0098888</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098888</ArticleId><ArticleId IdType="pmc">PMC4041783</ArticleId><ArticleId IdType="pubmed">24887237</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsuwanon P, Puenpa J, Huang SW, Wang YF, Mauleekoonphairoj J, Wang JR, Poovorawan Y. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci 2014; 21:16-28; PMID:24548776; http://dx.doi.org/10.1186/1423-0127-21-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-16</ArticleId><ArticleId IdType="pmc">PMC3937078</ArticleId><ArticleId IdType="pubmed">24548776</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PV, Thao NTT, Perera D, Huu TK, Tien NT, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot and mouth disease, southern Vietnam, 2005. Emerg Infect Dis 2007; 13:1733-41; PMID:18217559; http://dx.doi.org/10.3201/eid1307.060999</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1307.060999</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoa le PK, Chiang PS, Khanh TH, Luo ST, Dan TN, Wang YF, Thuong TC, Chung WY, Hung NT, Wang JR, et&#xa0;al.. Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam, 2011. PLoS One 2013; 8(7):e69895; PMID:23922846; http://dx.doi.org/10.1371/journal.pone.0069895</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069895</ArticleId><ArticleId IdType="pmc">PMC3726754</ArticleId><ArticleId IdType="pubmed">23922846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zander A, Britton PN, Navin T, Horsley E, Tobin S, McAnulty JM. An outbreak of enterovirus 71 in metropolitan Sydney: enhanced surveillance and lessons learnt. Med J Aust 2014; 201:663-6; PMID:25495312; http://dx.doi.org/10.5694/mja14.00014</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja14.00014</ArticleId><ArticleId IdType="pubmed">25495312</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen ML, Vuorinen T, Roivainen M. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J ClinVirol 2010; 48:49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20189452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly JL, Peigue-Lafeuille H. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect 2012; 18:E110-8; PMID:22404077; http://dx.doi.org/10.1111/j.1469-0691.2012.03789.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapusinszky B, Szomor KN, Farkas A, Tak&#xe1;cs M, Berencsi G. Detection of non-polioviruses in Hungary 2000-2008 and molecular epidemiology of enterovirus 71, coxsackievirus A16 and echovirus 30. Virus Genes 2010; 40:163-73; PMID:20044791; http://dx.doi.org/10.1007/s11262-009-0440-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-009-0440-4</ArticleId><ArticleId IdType="pubmed">20044791</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracho MA, Gonzales-Candelas F, Valero A, C&#xf3;rdoba J, Salazar A. Enterovirus co-infections and onychomadesis after hand, foot and mouth disease, Spain, 2008. Emerg Infect Dis 2011; 17:2223-1; PMID:22172227; http://dx.doi.org/10.3201/eid1712.110395</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1712.110395</ArticleId><ArticleId IdType="pmc">PMC3311182</ArticleId><ArticleId IdType="pubmed">22172227</ArticleId></ArticleIdList></Reference><Reference><Citation>Davia JL, Bel PH, Ninet VZ, Bracho MA, Gonz&#xe1;lez-Candelas F, Salazar A, Gobernado M, Bosch IF. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol 2011; 28:1-5; PMID:20553401; http://dx.doi.org/10.1111/j.1525-1470.2010.01161.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1470.2010.01161.x</ArticleId><ArticleId IdType="pubmed">20553401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M, Tarrago D, Munoz-Almagro C, Del Amo E, Dom&#xed;nguez-Gil M, Eiros JM, L&#xf3;pez-Miragaya I, P&#xe9;rez C, Reina J, Otero A, et&#xa0;al.. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated hand, foot and mouth disease in Spain. Clin Microbiol Infect 2014; 20:O150-6; PMID:24033818; http://dx.doi.org/10.1111/1469-0691.12361</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12361</ArticleId><ArticleId IdType="pubmed">24033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes M, Artieda J, Pineiro LD, Gastesi M, Diez-Nieves I, Cilla G. Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011. Emerg Infect Dis 2013; 19:676-8; PMID:23751014; http://dx.doi.org/10.3201/eid1904.121589</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1904.121589</ArticleId><ArticleId IdType="pmc">PMC3647425</ArticleId><ArticleId IdType="pubmed">23751014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair C, Gaunt E, Simmonds P, Broomfield D, Nwafor N, Wellington L, Templeton K, Willocks L, Schofield O, Harvala H. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill 2014; 19:20745-51; PMID:24698138</Citation><ArticleIdList><ArticleId IdType="pubmed">24698138</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization 
Hand, foot and mouth disease a rising menace in Asia. 13July2009
Available at
http://www.wpro.who.int/mediacentre/news/2009/2009013/en/</Citation></Reference><Reference><Citation>Abzug MJ. The enteroviruses: problems in need of treatment. J Infect 2014; 68 Suppl 1:S108-S114; PMID:24119825; http://dx.doi.org/10.1016/j.jinf.2013.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.09.020</ArticleId><ArticleId IdType="pubmed">24119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review of enterovirus 71 vaccines. Clin Infect Dis 2015; 60:797-803; PMID:25352588; http://dx.doi.org/10.1093/cid/ciu852</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu852</ArticleId><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Enterovirus vaccines for an emerging cause of brain-stem encephalitis. N Engl J Med 2014; 370:792-4; PMID:24571750; http://dx.doi.org/10.1056/NEJMp1400601</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1400601</ArticleId><ArticleId IdType="pubmed">24571750</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Ho TS, Lin HC, Lei HY, Wang JR, Liu CC. Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity. Eur J Microbiol Infect Dis 2012; 31:1219-24; PMID:21983920; http://dx.doi.org/10.1007/s10096-011-1432-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-011-1432-6</ArticleId><ArticleId IdType="pubmed">21983920</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang MC, Wang SM, Hsu YW, Lin HC, Chi CY, Liu CC. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 2006; 118:e1785-8; PMID:17116698; http://dx.doi.org/10.1542/peds.2006-1547</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-1547</ArticleId><ArticleId IdType="pubmed">17116698</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Deng C, Wan J, Zhu L, Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J 2011; 8:306-11; PMID:21679417; http://dx.doi.org/10.1186/1743-422X-8-306</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-306</ArticleId><ArticleId IdType="pmc">PMC3142239</ArticleId><ArticleId IdType="pubmed">21679417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R, Xu L, Zhang N, Zhu K, Yang J, Yang C, Deng C, Zhu Z, De Groot AS, Altmeyer R, et&#xa0;al.. Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease. Virus Res 2013; 177:62-5; PMID:23886670; http://dx.doi.org/10.1016/j.virusres.2013.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.07.009</ArticleId><ArticleId IdType="pubmed">23886670</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Cai C, Feng J, Li X, Wang Y, Yang J, Chen Z. Peripheral T lymphocyte subset imbalances in children with enterovirus 71-induced hand, foot and mouth disease. Virus Res 2014; 180:84-91; PMID:24316007; http://dx.doi.org/10.1016/j.virusres.2013.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.11.021</ArticleId><ArticleId IdType="pubmed">24316007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, Cheng AL, Fan TY, Chi H, Chang LY. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect 2012; 45:96-101; PMID:22154997; http://dx.doi.org/10.1016/j.jmii.2011.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.09.025</ArticleId><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Chetrit E, Wiener-Well Y, Shulman LM, Cohen MJ, Elinav H, Sofer D, Feldman I, Marva E, Wolf DG. Coxsackievirus A6-related hand, foot and mouth disease: skin manifestations in a cluster of adult patients. J Clin Virol 2014; 59:201-3; PMID:24457116; http://dx.doi.org/10.1016/j.jcv.2013.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.12.012</ArticleId><ArticleId IdType="pubmed">24457116</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing C, Ramirez-Fort MK, Doan HQ, Benoist F, Oberste MS, Khan F, Tyring SK. Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol 2014; 60:381-6; PMID:24932735; http://dx.doi.org/10.1016/j.jcv.2014.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.04.023</ArticleId><ArticleId IdType="pubmed">24932735</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizaki K, Tsuru T, Okumura K, Kondo N. [Three pediatric cases of group A coxsackievirus-associated encephalitis/encephalopathy]. No To Hattatsu 2012; 44:397-400; PMID:23012870</Citation><ArticleIdList><ArticleId IdType="pubmed">23012870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Yuan J, Wang X, Li J, Du J, Su H, Zhou B, Jin Q. Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen, China. Clin Infect Dis 2014; 59:1504-5; PMID:25091307; http://dx.doi.org/10.1093/cid/ciu624</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu624</ArticleId><ArticleId IdType="pubmed">25091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, Legakis NJ. Coxsackievirus B3 sequences in the myocardium of fatal cases in a cluster of acute myocarditis in Greece. J Clin Pathol 2005; 58:357-60; PMID:15790697; http://dx.doi.org/10.1136/jcp.2004.020099</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2004.020099</ArticleId><ArticleId IdType="pmc">PMC1770614</ArticleId><ArticleId IdType="pubmed">15790697</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu PY, Ke GM, Chen YS, Lu PL, Chen HL, Lee MS, Chen BC, Huang TS, Li YC, Chou LC, et&#xa0;al.. Molecular epidemiology of Coxsackievirus B3. Infect Genet Evol 2010; 10:777-84; PMID:20398802; http://dx.doi.org/10.1016/j.meegid.2010.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2010.04.004</ArticleId><ArticleId IdType="pubmed">20398802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CJ, Huang YC, Yang S, Tsao KC, Chen CJ, Hsieh YC, Chiu CH, Lin TY. Clinical features of coxsackievirus A4, B3 and B4 infections in infants. PLoS One 2014; 9(2):e87391; PMID:24504149; http://dx.doi.org/10.1371/journal.pone.0087391</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087391</ArticleId><ArticleId IdType="pmc">PMC3913601</ArticleId><ArticleId IdType="pubmed">24504149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kang B, Hwang S, Hong J, Kim K, Cheon DS. Epidemics of viral meningitis cause by echovirus 6 and 30 in Korea in 2008. Virol J 2012; 9:38-44; PMID:22336050; http://dx.doi.org/10.1186/1743-422X-9-38</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-38</ArticleId><ArticleId IdType="pmc">PMC3298778</ArticleId><ArticleId IdType="pubmed">22336050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6:279-89; PMID:20351698; http://dx.doi.org/; http://dx.doi.org/10.1038/nrendo.2010.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2010.27</ArticleId><ArticleId IdType="pubmed">20351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu PC, Huang LM, Kao CL, Fan TY, Cheng AL, Chang LY. An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei. J Microbiol Immunol Infect 2010; 43:271-7; PMID:20688286; http://dx.doi.org/10.1016/S1684-1182(10)60043-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1684-1182(10)60043-6</ArticleId><ArticleId IdType="pubmed">20688286</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazawa I, Azegami Y, Kasuo S, Yoshida T, Kobayashi M, Shiraishi T. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007. Jpn J Infect Dis 2008; 61:747-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18503184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Ito M, Tanigushi A, Sakae K. Prevalence of coxsackievirus A5, A6 and A10 in patients with herpangina in Aichi Prefecture, 2005. Jpn J Infect Dis 2005; 58:390-1; PMID:16377876</Citation><ArticleIdList><ArticleId IdType="pubmed">16377876</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science 2012; 336:1274-7; PMID:22383808; http://dx.doi.org/10.1126/science.1218713</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K, Wang GC, He YL, Han JF, Ye Q, Qin CF, Chen R. Crystal structure of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design. J Biol Chem 2015; 290:3198-208; PMID:25492868; http://dx.doi.org/10.1074/jbc.M114.624536</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.624536</ArticleId><ArticleId IdType="pmc">PMC4318995</ArticleId><ArticleId IdType="pubmed">25492868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder JD, Cifuente JO, Pan J, Bergelson JM, Hafenstein S. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface. J Virol 2012; 86:12571-81; PMID:22973031; http://dx.doi.org/10.1128/JVI.01592-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01592-12</ArticleId><ArticleId IdType="pmc">PMC3497627</ArticleId><ArticleId IdType="pubmed">22973031</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. Update on enterovirus 71 infection. Curr Opin Virol 2014; 5:98-104; PMID:24727707; http://dx.doi.org/10.1016/j.coviro.2014.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wang YC, Chen YC, Yang CS, Chong PC. Purification and characterization of enterovirus 71 particles produced from vero cells grown in serum-free microcarrier bioreactor system. PLoS One 2011; 6(5):e20005; PMID:21603631; http://dx.doi.org/10.1371/journal.pone.0020005</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020005</ArticleId><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Shih SR. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J Biomed Sci 2014; 21:18-23; PMID:24602216; http://dx.doi.org/10.1186/1423-0127-21-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-18</ArticleId><ArticleId IdType="pmc">PMC3995930</ArticleId><ArticleId IdType="pubmed">24602216</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol 2015; 235:217-28; PMID:25211036; http://dx.doi.org/10.1002/path.4438</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009; 15:794-7; PMID:19543284; http://dx.doi.org/10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi A, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009; 15:798-801; PMID:19543282; http://dx.doi.org/10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi A, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 2013; 87:3335-47; PMID:23302872; http://dx.doi.org/10.1128/JVI.02070-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 2011; 85:11809-20; PMID:21900167; http://dx.doi.org/10.1128/JVI.00297-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparin sulfate glycoaminoglycan as an attachment receptor. J Virol 2013; 87:611-20; PMID:23097443; http://dx.doi.org/10.1128/JVI.02226-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Liu YT, Chang HY, Huang SW, Wang YF, Yu CK, Wang JR, Chang CF. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol 2012; 12:162-73; PMID:22853823; http://dx.doi.org/10.1186/1471-2180-12-162</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren XX, Ma L, Liu QW, Li C, Huang Z, Wu L, Xiong SD, Wang JH, Wang HB. The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol J 2014; 11:47-55; PMID:24620896; http://dx.doi.org/10.1186/1743-422X-11-47</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-47</ArticleId><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 2005; 79:655-60; PMID:15596863; http://dx.doi.org/10.1128/JVI.79.1.655-660.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.655-660.2005</ArticleId><ArticleId IdType="pmc">PMC538729</ArticleId><ArticleId IdType="pubmed">15596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopoulos G, Triantafilou K, Triantafilou M. Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol 2004; 74:291-9; PMID:15332279; http://dx.doi.org/10.1002/jmv.20184</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20184</ArticleId><ArticleId IdType="pubmed">15332279</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsueng G, Tabor-Godwin JM, Gopal A, Ruller CM, Deline S, An N, Frausto RF, Milner R, Crocker SJ, Whitton JL, et&#xa0;al.. Coxsackievirus preferentially replicates and induces cytopathic effect in undifferentiated neural progenitor cells. J Virol 2011; 85:5718-32; PMID:21471247; http://dx.doi.org/10.1128/JVI.02261-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02261-10</ArticleId><ArticleId IdType="pmc">PMC3126326</ArticleId><ArticleId IdType="pubmed">21471247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylipaasto P, Eskelinen M, Salmela K, Hovi T, Roivainen M. Vitronectin receptors, alpha v integrins, are recognized by several non-RGD-containing echoviruses in a continuous laboratory cell line and also in primary human Langerhans' islets and endothelial cells. J Gen Virol 2010; 91:155-65; PMID:19776235; http://dx.doi.org/10.1099/vir.0.012450-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.012450-0</ArticleId><ArticleId IdType="pubmed">19776235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW, Yeo SG, Kang BH, Lee HK, Kim JW, Lee SH, Kim KS, Cheon DS. Echovirus 30 induced neuronal cell death through TRIO-RhoA signaling activation. PLoS One 2012; 7(5):e36656; PMID:22586486; http://dx.doi.org/10.1371/journal.pone.0036656</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036656</ArticleId><ArticleId IdType="pmc">PMC3346726</ArticleId><ArticleId IdType="pubmed">22586486</ArticleId></ArticleIdList></Reference><Reference><Citation>Sickles GM, Mutterer M, Feorino P, Plager H. Recently classified types of Coxsackie virus, group A: behavior in tissue culture. Proc Soc Exp Biol Med 1955; 90:529-31; PMID:13273503; http://dx.doi.org/10.3181/00379727-90-22088</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-90-22088</ArticleId><ArticleId IdType="pubmed">13273503</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Ass J 1958; 79:615-21; PMID:13585281</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1830188</ArticleId><ArticleId IdType="pubmed">13585281</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop J, Flewett TH, Foster JR. &#x201c;Hand-foot-and-mouth&#x201d; disease in Birmingham in 1959. Br Med J 1960; 2:1708-11; PMID:13682692; http://dx.doi.org/10.1136/bmj.2.5214.1708</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5214.1708</ArticleId><ArticleId IdType="pmc">PMC2098292</ArticleId><ArticleId IdType="pubmed">13682692</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974; 129:304-9; PMID:4361245; http://dx.doi.org/10.1093/infdis/129.3.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiff A. Cambodia unravels cause of mystery illness. Lancet 2012; 380:206; PMID:22826834; http://dx.doi.org/10.1016/S0140-6736(12)61200-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61200-8</ArticleId><ArticleId IdType="pubmed">22826834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, et&#xa0;al.. Enterovirus 71 outbreaks in the People's Republic of China in 2008. J Clin Microbiol 2009; 47:2351-2; PMID:19439545; http://dx.doi.org/10.1128/JCM.00563-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, et&#xa0;al.. Hand, foot and mouth disease in China, 2008-12: an epidemiology study. Lancet Infect Dis 2014; 14:30-8-318; PMID:24485991; http://dx.doi.org/10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yu J, Liu L, Wei Z, Ehrlich ES, Liu G, Li J, Liu X, Wang H, Yu XF, et&#xa0;al.. Coxsackievirus A16 infection induces neural cell and non-neural cells apoptosis in vitro. PLoS One 2014; 9(10):e111174; PMID:25350381; http://dx.doi.org/10.1371/journal.pone.0111174</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111174</ArticleId><ArticleId IdType="pmc">PMC4211689</ArticleId><ArticleId IdType="pubmed">25350381</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M, Razafindratsimandresy R, Nougair&#xe8;de A, Joffret ML, Deshpande JM, Dubot-P&#xe9;r&#xe8;s A, H&#xe9;raud JM, de Lamballerie X, Delpeyroux F, Bailly JL. et&#xa0;al. Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS One 2014; 9(3):e90624; PMID:24598878; http://dx.doi.org/10.1371/journal.pone.0090624</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090624</ArticleId><ArticleId IdType="pmc">PMC3944068</ArticleId><ArticleId IdType="pubmed">24598878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Katsushima F, Katsushima Y, Ito S, Hongo S, Matsuzaki Y. Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J Med Microbiol 2014; 63:1356-62; PMID:25053796; http://dx.doi.org/10.1099/jmm.0.079699-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.079699-0</ArticleId><ArticleId IdType="pubmed">25053796</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia MY, Chiang PS, Chung WY, Luo ST, Lee MS. Epidemiology of enterovirus 71 infections in Taiwan. Pediatr Neonatolo 2014; 55:243-9; PMID:24120535; http://dx.doi.org/10.1016/j.pedneo.2013.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2013.07.007</ArticleId><ArticleId IdType="pubmed">24120535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong W, He Y, Yu S, Yang H, Xian H, Liao Y, Hu G. Molecular phylogeny of Coxsackievirus A16 in Shenzhen, China, from 2005 to 2009. J Clin Microbiol 2011; 49:1659-61; PMID:21325543; http://dx.doi.org/10.1128/JCM.00010-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00010-11</ArticleId><ArticleId IdType="pmc">PMC3122795</ArticleId><ArticleId IdType="pubmed">21325543</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang E, Zhao H, Zhang Y, Liu J, Liao Y, Wang L, Cui P, Yang L, Liu L, Dong C, et&#xa0;al.. A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B). Sci China Life Sci 2012; 55:336-42; PMID:22566090; http://dx.doi.org/10.1007/s11427-012-4313-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-012-4313-z</ArticleId><ArticleId IdType="pubmed">22566090</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek KA, Yeo SG, Lee BH, Park K, Song J, Yu J, Rheem I, Kim J, Hwang S, Choi Y, et&#xa0;al.. Epidemics of enterovirus infection in Chungnam Korea, 2008-2009. Virol J 2011; 8:297-305; PMID:21668960; http://dx.doi.org/10.1186/1743-422X-8-297</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-297</ArticleId><ArticleId IdType="pmc">PMC3130694</ArticleId><ArticleId IdType="pubmed">21668960</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake JW, Charlesworth B, Charlesworth D, Cow JF. Rates of spontaneous mutations. Genetics 1998; 148:1667-86; PMID:9560386</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1460098</ArticleId><ArticleId IdType="pubmed">9560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Cheng HL, Hsieh HY, Chang CL, Tsai HP, Kuo PH, Wang SM, Liu CC, Su IJ, Wang JR. Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71. J Biomed Sci 2014; 21:33-47; PMID:24766641; http://dx.doi.org/10.1186/1423-0127-21-33</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-33</ArticleId><ArticleId IdType="pmc">PMC4021180</ArticleId><ArticleId IdType="pubmed">24766641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Du J, Hu Y, Wang X, Xue Y, Dong J, Sun L, Li Z, Li Y, Sun S, et&#xa0;al.. Enterovirus coinfection during an outbreak of hand, foot and mouth disease in Shangdong, China. Clin Infect Dis 2011; 53:400-1; PMID:21785005; http://dx.doi.org/10.1093/cid/cir346</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir346</ArticleId><ArticleId IdType="pubmed">21785005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Du J, Xue Y, Su H, Yang F, Jin Q. Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand, foot and mouth disease in Shangdong China in 2010 and 2011. PLoS One 2013; 8(6):e67157; PMID:23840610; http://dx.doi.org/10.1371/journal.pone.0067157</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067157</ArticleId><ArticleId IdType="pmc">PMC3686723</ArticleId><ArticleId IdType="pubmed">23840610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Han X, Wang G, Hu W, Zhang W, Yu XF. Circulating coxsackievirus A16 identified as recombinant type A human enteroviruses, China. Emerg Infect Dis 2011; 17:1537-40; PMID:21801645</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381541</ArticleId><ArticleId IdType="pubmed">21801645</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Tan X, Li J, Jin Y, Gong L, Hong M, Shi Y, Zhu S, Zhang B, Zhang S, et&#xa0;al.. Molecular epidemiology of coxsackievirus A16: Intratype and prevalent intertype recombination identified. PLoS One 2013; 8(12):e82861; PMID:24340064; http://dx.doi.org/10.1371/journal.pone.0082861</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082861</ArticleId><ArticleId IdType="pmc">PMC3858299</ArticleId><ArticleId IdType="pubmed">24340064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Du J, Zhang T, Xue Y, Yang F, Jin Q. Recombinant human coxsackievirus B3 from children with acute myocarditis in China. J Clin Microbiol 2013; 51:3083-6; PMID:23804378; http://dx.doi.org/10.1128/JCM.00270-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00270-13</ArticleId><ArticleId IdType="pmc">PMC3754657</ArticleId><ArticleId IdType="pubmed">23804378</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Lai S, Zhang H, Wang L, Zhou D, Liu J, Lan Y, Ma J, Yu H, Buckeridge DL, et&#xa0;al.. Hand, foot and mouth disease in China: evaluating an automated system for detection of outbreaks. Bull World Health Organ 2014; 92:656-63; PMID:25378756; http://dx.doi.org/10.2471/BLT.13.130666</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.13.130666</ArticleId><ArticleId IdType="pmc">PMC4208569</ArticleId><ArticleId IdType="pubmed">25378756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Fu Y, Ju L, Miao X, Shen Y, He L, Wang W, Jin J, Shao L, Sampath R, Ecker DJ, et&#xa0;al.. Detection and identification of viral pathogens in patients with hand, foot and mouth disease by multilocus PCR, reverse-transcription PCR and electrospray ionization mass spectrometry. J Clin Virol 2014; 59:115-9; PMID:24365476; http://dx.doi.org/10.1016/j.jcv.2013.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.11.007</ArticleId><ArticleId IdType="pubmed">24365476</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein MH. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev Vaccines 2015; 14:337-40; PMID:25536888; http://dx.doi.org/10.1586/14760584.2015.993385</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2015.993385</ArticleId><ArticleId IdType="pubmed">25536888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M. Production of EV71 vaccine candidates. Hum Vaccin Immunother 2012; 8:1775-83; PMID:22992566; http://dx.doi.org/10.4161/hv.21739</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.21739</ArticleId><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung YA, Hung CT, Liu YC, Shih SR. Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther 2014; 14:1455-64; PMID:24989170; http://dx.doi.org/10.1517/14712598.2014.935330</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2014.935330</ArticleId><ArticleId IdType="pubmed">24989170</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YX, Zhao H, Cao RY, Deng YQ, Han JF, Zhu SY, Ma J, Liu L, Qin ED, Qin CF1. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Virol J 2014; 11:79-87; PMID:24885030; http://dx.doi.org/10.1186/1743-422X-11-79</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-79</ArticleId><ArticleId IdType="pmc">PMC4030048</ArticleId><ArticleId IdType="pubmed">24885030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Jiang S, Wang Y. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem Biophys Res Commun 2013; 430:387-93; PMID:23159634; http://dx.doi.org/10.1016/j.bbrc.2012.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.11.035</ArticleId><ArticleId IdType="pubmed">23159634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou AH, Liu CC, Chang JY, Lien SP, Guo MS, Tasi HP, Hsiao KN, Liu SJ, Sia C, Wu SC, et&#xa0;al.. Immunological evaluation and comparison of different EV71 vaccine candidates. Clin Dev Immunol 2012; 2012:831282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3447357</ArticleId><ArticleId IdType="pubmed">23008736</ArticleId></ArticleIdList></Reference><Reference><Citation>Premanand B, Kiener TK, Meng T, Tan YR, Jia Q, Chow VT, Kwang J. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Antiviral Res 2012; 95:311-5; PMID:22691220; http://dx.doi.org/10.1016/j.antiviral.2012.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.05.017</ArticleId><ArticleId IdType="pubmed">22691220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolpe AB, Kiener TK, Grotenbreg GM, Kwang J. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice. Virus Res 2012; 168:64-72; PMID:22728446; http://dx.doi.org/10.1016/j.virusres.2012.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.06.014</ArticleId><ArticleId IdType="pubmed">22728446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung WS, Bakar SA, Sekawi Z, Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune responses in mice. Genet Vaccines 2007; 5:6-18; PMID:17445254; http://dx.doi.org/10.1186/1479-0556-5-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-0556-5-6</ArticleId><ArticleId IdType="pmc">PMC3225814</ArticleId><ArticleId IdType="pubmed">17445254</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X, Su X, Li X, Li H, Li T, Zhou Z, Zhong T, Zhou R. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon. PLoS One 2012; 7(7):e41381; PMID:22848478; http://dx.doi.org/10.1371/journal.pone.0041381</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041381</ArticleId><ArticleId IdType="pmc">PMC3407240</ArticleId><ArticleId IdType="pubmed">22848478</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HY, Han JF, Qin CF, Chen R. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 2013; 31:3281-7; PMID:23726823; http://dx.doi.org/10.1016/j.vaccine.2013.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.05.019</ArticleId><ArticleId IdType="pubmed">23726823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 2012; 30:1305-12; PMID:22214888; http://dx.doi.org/10.1016/j.vaccine.2011.12.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.12.081</ArticleId><ArticleId IdType="pubmed">22214888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HF, Chang MH, Chiang BL, Jeng ST. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006; 24:2944-51; PMID:16448730; http://dx.doi.org/10.1016/j.vaccine.2005.12.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2005.12.047</ArticleId><ArticleId IdType="pubmed">16448730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Hao C, Zhang S, Li A, Zhang Q, Wu W, Liu L, Li C, Liang M, Li X, et&#xa0;al.. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Virol J 2014; 11:80-8; PMID:24885121; http://dx.doi.org/10.1186/1743-422X-11-80</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-80</ArticleId><ArticleId IdType="pmc">PMC4022980</ArticleId><ArticleId IdType="pubmed">24885121</ArticleId></ArticleIdList></Reference><Reference><Citation>Premanand B, Prabakaran M, Kiener TK, Kwang J. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One 2013; 8(2):e55536; PMID:23390538; http://dx.doi.org/10.1371/journal.pone.0055536</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055536</ArticleId><ArticleId IdType="pmc">PMC3563597</ArticleId><ArticleId IdType="pubmed">23390538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CH, Chu C, He CC, Lin TY. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect 2006; 8:1671-8; PMID:16815726; http://dx.doi.org/10.1016/j.micinf.2006.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2006.01.021</ArticleId><ArticleId IdType="pubmed">16815726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Huana Z, Sao C, Huang Y, Zhang F, Ma G, Chen Z, Zeng Z, Qiwen D, Zeng W. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Arch Virol 2013; 158:1071-7; PMID:23275129; http://dx.doi.org/10.1007/s00705-012-1589-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1589-z</ArticleId><ArticleId IdType="pubmed">23275129</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 2005; 86:1391-401; PMID:15831951; http://dx.doi.org/10.1099/vir.0.80784-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T, Kwang J. Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J Virol 2014; 88:5803-15; PMID:24623423; http://dx.doi.org/10.1128/JVI.00289-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00289-14</ArticleId><ArticleId IdType="pmc">PMC4019108</ArticleId><ArticleId IdType="pubmed">24623423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek EJ, Hussain KM, Phuektes P, Kok CC, Gao Q, Cai F, Gao Z, McMinn PC. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine 2011; 29:4829-38; PMID:21550375; http://dx.doi.org/10.1016/j.vaccine.2011.04.070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.070</ArticleId><ArticleId IdType="pubmed">21550375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Liu L, Zhao H, Wang J, Liao Y, Zhang X, Na R, Liang Y, Wang L, Li Q. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 2011; 29:6269-75; PMID:21722686; http://dx.doi.org/10.1016/j.vaccine.2011.06.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.06.044</ArticleId><ArticleId IdType="pubmed">21722686</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, et&#xa0;al.. A phase 1, randomized, open-label study to evaluate the safety and immunogenicity of enterovirus 71 vaccine. Vaccine 2013; 31:2471-6; PMID:23541623; http://dx.doi.org/10.1016/j.vaccine.2013.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.015</ArticleId><ArticleId IdType="pubmed">23541623</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou AH, Liu CC, Chang JY, Jiang R, Hsieh YC, Tsao A, Wu CL, Huang JL, Fung CP, Hsieh SM, et&#xa0;al.. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody responses against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One 2013; 8(11):e79783; PMID:24278177; http://dx.doi.org/10.1371/journal.pone.0079783</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079783</ArticleId><ArticleId IdType="pmc">PMC3836818</ArticleId><ArticleId IdType="pubmed">24278177</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Mao QY, Liang ZL, Ji H, Zhu FC. Development of enterovirus 71 vaccines: from the lab bench to phase III clinical trials. Expert Rev Vaccines 2014; 13:609-18; PMID:24621093; http://dx.doi.org/10.1586/14760584.2014.897617</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2014.897617</ArticleId><ArticleId IdType="pubmed">24621093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et&#xa0;al.. Efficacy, safety, and immunology of an inactivated alum-adjuvanted enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 38:2024-32; http://dx.doi.org/10.1016/S0140-6736(13)61049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et&#xa0;al.. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370:818-28; PMID:24571754; http://dx.doi.org/10.1056/NEJMoa1304923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et&#xa0;al.. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014; 370:829-37; PMID:24571755; http://dx.doi.org/10.1056/NEJMoa1303224</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Cheng T, Zhu F, Li J, Wang Y, Li Y, Gao F, Yang L, Yao X, Shao J, et&#xa0;al.. The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy Chinese infants and children. PLoS One 2013; 8(11):e79599; PMID:24260259; http://dx.doi.org/10.1371/journal.pone.0079599</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079599</ArticleId><ArticleId IdType="pmc">PMC3834186</ArticleId><ArticleId IdType="pubmed">24260259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Qi S, Zhang X, Zhang Y, Liu L, Che Y, He Z, Zhao Y, Lu S, Yu W, et&#xa0;al.. Coxsackievirus A16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in Rhesus monkeys. Vaccine 2014; 32:4436-42; PMID:24958699; http://dx.doi.org/10.1016/j.vaccine.2014.06.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.062</ArticleId><ArticleId IdType="pubmed">24958699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YJ, Meng FY, Mao QY, Chen YJ, Meng FY, Mao Q, Li JX, Wang H, Liang ZL, Zhang YT, et&#xa0;al.. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial. Hum Vaccin Immunother 2014; 10:1366-72; PMID:24633366; http://dx.doi.org/10.4161/hv.28397</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.28397</ArticleId><ArticleId IdType="pmc">PMC4896521</ArticleId><ArticleId IdType="pubmed">24633366</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Huang X, Liu Q, Huang Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine 2013; 31:2130-6; PMID:23499595; http://dx.doi.org/10.1016/j.vaccine.2013.02.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.02.051</ArticleId><ArticleId IdType="pubmed">23499595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Guo MS, Lin FH, Hsiao KN, Weng SY, Chou AH, Wang JR, Hsieh SY, Su IJ, Liu CC. Immunological and biochemical characterization of coxsackie virus A16 viral particles. PLoS One 2012; 7(11):e499973; PMID:23226233; http://dx.doi.org/10.1371/journal.pone.0049973</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049973</ArticleId><ArticleId IdType="pmc">PMC3511423</ArticleId><ArticleId IdType="pubmed">23226233</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 2013; 31:2215-21; PMID:23499596; http://dx.doi.org/10.1016/j.vaccine.2013.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.007</ArticleId><ArticleId IdType="pubmed">23499596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang E, Cheng C, Zhang Y, Wang J, Che Y, Pu J, Dong C, Liu L, He Z, Lu S, et&#xa0;al.. Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother 2014; 10:1266-73; PMID:24583556; http://dx.doi.org/10.4161/hv.28083</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.28083</ArticleId><ArticleId IdType="pmc">PMC4896597</ArticleId><ArticleId IdType="pubmed">24583556</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chang J, Liu X, Yang J, Guo H, Wei W, Zhang W, Yu XF. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J Gen Virol 2014; 95:1083-93; PMID:24496826; http://dx.doi.org/10.1099/vir.0.063560-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.063560-0</ArticleId><ArticleId IdType="pmc">PMC3983757</ArticleId><ArticleId IdType="pubmed">24496826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Li HY, Han JF, Deng YQ, Li YX, Zhu SY, He YL, Qin ED, Chen R, Qin CF. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice. Appl Microbiol Biotechnol 2013; 97:10445-52; PMID:24085395; http://dx.doi.org/10.1007/s00253-013-5257-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-013-5257-3</ArticleId><ArticleId IdType="pubmed">24085395</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Ku Z, Liu Q, Leng Q, Huang Z. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine 2014; 32:2406-12; PMID:24657161; http://dx.doi.org/10.1016/j.vaccine.2014.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.03.012</ArticleId><ArticleId IdType="pubmed">24657161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Liu CC, Lu TC, Liu SJ, Chow YH, Chong P, Huang MH. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems. Biomed Res Int 2014; 2014:670506; PMID:25006583</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071850</ArticleId><ArticleId IdType="pubmed">25006583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Liu Q, Ye X, Cai Y, Wang X, Shi J, Li D, Jin X, An W, Huang Z. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 2014; 32:4296-303; PMID:24950363; http://dx.doi.org/10.1016/j.vaccine.2014.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.025</ArticleId><ArticleId IdType="pubmed">24950363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Li HY, Han JF, Deng YQ, Zhu SY, Li XF, Yang HQ, Li YX, Zhang Y, Qin ED, et&#xa0;al.. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice. Sci Rep 2015; 5:7878-85; PMID:25597595; http://dx.doi.org/10.1038/srep07878</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep07878</ArticleId><ArticleId IdType="pmc">PMC4297979</ArticleId><ArticleId IdType="pubmed">25597595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, Li X, Jin J, Xu L, Zhao D, et&#xa0;al.. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Hum Vaccin Immunother 2014; 10:2885-95; PMID:25483672; http://dx.doi.org/10.4161/hv.29823</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.29823</ArticleId><ArticleId IdType="pmc">PMC5443096</ArticleId><ArticleId IdType="pubmed">25483672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chow YH, Chong P, Klein M. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine 2014; 32:6177-82; PMID:25218294; http://dx.doi.org/10.1016/j.vaccine.2014.08.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.08.064</ArticleId><ArticleId IdType="pubmed">25218294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, Nam JH. Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines. Expert Opin Biol Ther 2010; 10:179-90; PMID:20088713; http://dx.doi.org/10.1517/14712590903379502</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712590903379502</ArticleId><ArticleId IdType="pubmed">20088713</ArticleId></ArticleIdList></Reference><Reference><Citation>Fohlman J, Pauksen K, Morein B, Bjare U, Ilb&#xe4;ck NG, Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccines protective effect against experimental myocarditis. Scand J Infect Dis Suppl 1993; 88:103-8; PMID:8390713</Citation><ArticleIdList><ArticleId IdType="pubmed">8390713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jrad-Battikh N, Souli A, Oueslati L, Aouni M, Hober D, Gharbi J, Ben M'hadheb-Gharbi M. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection. Curr Microbiol 2014; 68:503-9; PMID:24322405; http://dx.doi.org/10.1007/s00284-013-0498-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-013-0498-z</ArticleId><ArticleId IdType="pubmed">24322405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Gao Z, Xiong H, Chuai X, Jin Y, Li J, Xian X, Liu G, Xie L, Zhang Y, et&#xa0;al.. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination, Vaccine 2011; 29:6894-902; PMID:21803097; http://dx.doi.org/10.1016/j.vaccine.2011.07.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.07.049</ArticleId><ArticleId IdType="pubmed">21803097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Yue Y, Dong C, Li X, Xu W, Xiong S. Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis. Clin Vaccine Immunol 2013; 20:1743-51; PMID:24027262; http://dx.doi.org/10.1128/CVI.00466-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00466-13</ArticleId><ArticleId IdType="pmc">PMC3837774</ArticleId><ArticleId IdType="pubmed">24027262</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune responses and protects mice against myocarditis. Vaccine 2012; 30:2301-08; PMID:22306858; http://dx.doi.org/10.1016/j.vaccine.2012.01.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.01.061</ArticleId><ArticleId IdType="pubmed">22306858</ArticleId></ArticleIdList></Reference><Reference><Citation>Koho T, Koivunene MR, Oikarinen S, Kummola L, M&#xe4;kinen S, M&#xe4;h&#xf6;nen AJ, Sioofy-Khojine A, Marjom&#xe4;ki V, Kazmertsuk A, Junttila I, et&#xa0;al.. Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice. Antiviral Res 2014; 104:93-101; PMID:24485896; http://dx.doi.org/10.1016/j.antiviral.2014.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.01.013</ArticleId><ArticleId IdType="pubmed">24485896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Fan X, Yue Y, Xiong S, Dong C. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis. Vaccine 2014; 32:3917-26; PMID:24874923; http://dx.doi.org/10.1016/j.vaccine.2014.05.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.05.052</ArticleId><ArticleId IdType="pmc">PMC7115516</ArticleId><ArticleId IdType="pubmed">24874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Cao RY, Deng YQ, Tian X, Jiang T, Qin ED, Qin CF. Antibody-dependent enhancement of infection of enterovirus 71 in vitro and in vivo. Virol J 2011; 8:106-12; PMID:21385398; http://dx.doi.org/10.1186/1743-422X-8-106</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-106</ArticleId><ArticleId IdType="pmc">PMC3060144</ArticleId><ArticleId IdType="pubmed">21385398</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li J, Liang Z, Xiuling L, Qunying M, Fanyue M, Hua W, Yuntao Z, Fan G, Qinghua C, et&#xa0;al.. A booster dose of an inactivated enterovirus vaccine in Chinese young children: a randomized, double-blind, placebo controlled clinical trials. J Infect Dis 2014; 210:1073-82; PMID:24625805; http://dx.doi.org/10.1093/infdis/jiu113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu113</ArticleId><ArticleId IdType="pubmed">24625805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Yu CK. Animal models for enterovirus 71 infection: application and limitations. J Biomed Sci 2014; 21:31-41; PMID:24742252; http://dx.doi.org/10.1186/1423-0127-21-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 2012; 86:11967-76; PMID:22951825; http://dx.doi.org/10.1128/JVI.00902-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SI, Shao HY, Lin HY, Liu CC, Hsiao KN, Chitra E, Tsou YL, Chang HW, Sia C, et&#xa0;al.. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One 2013; 8(2):e57591; PMID:23451246; http://dx.doi.org/10.1371/journal.pone.0057591</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA 2013; 110:14753-8; PMID:23959904; http://dx.doi.org/10.1073/pnas.1217563110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, Lin YW, Ho HM, Lin MH, Liu CC, Shao HY, Chong P, Sia C, Chow YH. Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS One 2013; 8:269858; PMID:23936115; http://dx.doi.org/10.1371/annotation/e71a42ed-eebf-43c1-b2f5-6ea70e9d8966</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/e71a42ed-eebf-43c1-b2f5-6ea70e9d8966</ArticleId><ArticleId IdType="pmc">PMC3728341</ArticleId><ArticleId IdType="pubmed">23936115</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ST, Chiang PS, Chao AS, Liou GY, Lin R, Lin TY, Lee MS. Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg Infect Dis 2009; 15:581-4; PMID:19331737; http://dx.doi.org/10.3201/1504.081550</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/1504.081550</ArticleId><ArticleId IdType="pmc">PMC2671432</ArticleId><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CW, Lee YP, Wang YF, Yu CK. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine. Vaccine 2011; 29:2772-6; PMID:21315698; http://dx.doi.org/10.1016/j.vaccine.2011.01.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.01.094</ArticleId><ArticleId IdType="pubmed">21315698</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Shao J, Ying Z, Gao F, Yao X, Li C, Ye Q, Xu M, Li R, et&#xa0;al.. The compatibility of inactivated Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals. Hum Vaccin Immunother 2015; PMID:25715318; http://dx.doi.org/10.1080/21645515.2015.1011975</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1011975</ArticleId><ArticleId IdType="pmc">PMC4685687</ArticleId><ArticleId IdType="pubmed">25715318</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Yin H, An Z, Feng Z. Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine 2015; 33:1107-12; PMID:25444807; http://dx.doi.org/10.1016/j.vaccine.2014.10.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.10.081</ArticleId><ArticleId IdType="pubmed">25444807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BY, Wateska AR, Bailey RR, Tai JH, Bacon KM, Smith KJ. Forecasting the economic value of an enterovirus 71 EV71 vaccine. Vaccine 2010; 28:7731-6; PMID:20923711; http://dx.doi.org/10.1016/j.vaccine.2010.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.09.065</ArticleId><ArticleId IdType="pmc">PMC2989421</ArticleId><ArticleId IdType="pubmed">20923711</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wang J. EV71 vaccine, an invaluable gift for children. Clin Transl Immunol 2014; 3:e28; PMID:25505956; http://dx.doi.org/10.1038/cti.2014.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2014.24</ArticleId><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, Molet L, Hassel C, Peigue-Lafeuille HC, Rozenberg F, Bailly JL, Henquell CC. Enterovirus A71 subgenotype B5, France, 2013. Emerg Infect Dis 2015; 21:707-9; PMID:25811300; http://dx.doi.org/10.3201/eid2104.141093</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2104.141093</ArticleId><ArticleId IdType="pmc">PMC4378463</ArticleId><ArticleId IdType="pubmed">25811300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>